1. Home
  2. OII vs SUPN Comparison

OII vs SUPN Comparison

Compare OII & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OII
  • SUPN
  • Stock Information
  • Founded
  • OII 1964
  • SUPN 2005
  • Country
  • OII United States
  • SUPN United States
  • Employees
  • OII N/A
  • SUPN N/A
  • Industry
  • OII Oilfield Services/Equipment
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • OII Energy
  • SUPN Health Care
  • Exchange
  • OII Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • OII 2.1B
  • SUPN 2.0B
  • IPO Year
  • OII N/A
  • SUPN 2012
  • Fundamental
  • Price
  • OII $22.36
  • SUPN $42.64
  • Analyst Decision
  • OII Hold
  • SUPN Buy
  • Analyst Count
  • OII 5
  • SUPN 2
  • Target Price
  • OII $28.25
  • SUPN $41.00
  • AVG Volume (30 Days)
  • OII 854.2K
  • SUPN 1.0M
  • Earning Date
  • OII 07-23-2025
  • SUPN 08-05-2025
  • Dividend Yield
  • OII N/A
  • SUPN N/A
  • EPS Growth
  • OII 63.71
  • SUPN 1411.53
  • EPS
  • OII 1.98
  • SUPN 1.14
  • Revenue
  • OII $2,765,945,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • OII $5.07
  • SUPN N/A
  • Revenue Next Year
  • OII $3.04
  • SUPN $15.74
  • P/E Ratio
  • OII $11.29
  • SUPN $37.26
  • Revenue Growth
  • OII 8.14
  • SUPN 5.55
  • 52 Week Low
  • OII $15.46
  • SUPN $29.16
  • 52 Week High
  • OII $30.98
  • SUPN $43.62
  • Technical
  • Relative Strength Index (RSI)
  • OII 56.31
  • SUPN 78.08
  • Support Level
  • OII $21.03
  • SUPN $40.26
  • Resistance Level
  • OII $22.50
  • SUPN $43.62
  • Average True Range (ATR)
  • OII 0.74
  • SUPN 1.76
  • MACD
  • OII -0.04
  • SUPN 0.70
  • Stochastic Oscillator
  • OII 51.64
  • SUPN 91.16

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: